Aspirin in the primary prevention of vascular disease.
Cleland
John G F
JG
D001241:Aspirin / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D006801:Humans; D015201:Meta-Analysis as Topic; D009203:Myocardial Infarction / Q000453:epidemiology / Q000209:etiology; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011322:Primary Prevention / Q000379:methods*; D011655:Pulmonary Embolism / Q000150:complications / Q000517:prevention & control; D055502:Secondary Prevention / Q000379:methods; D014652:Vascular Diseases / Q000150:complications / Q000517:prevention & control*
D010975:Platelet Aggregation Inhibitors; D001241:Aspirin